Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27162316 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL347708 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL347560 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL27933002 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL347196 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL347112 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL345738 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL346332 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL347146 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 | |
| SCHEMBL27933170 | 1.00 | DGKA (0.62) | DGKAMAPTPRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2593075-A2 | A PERSONAL CARE COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED COMPOUND | The Procter and Gamble Company (US) | 2013-05-22 | — | — | EP | claimed |
| US-20120014900-A1 | Personal Care Composition Comprising a Near-Terminal Branched Compound | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | claimed |
| WO-2012009523-A2 | A PERSONAL CARE COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-19 | — | — | WO | claimed |
| WO-2019113813-A1 | A HAIR CLEANSING COMPOSITION | BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD. (CN) | 2019-06-20 | — | — | WO | disclosed |
| WO-2019115156-A1 | A HAIR CLEANSING COMPOSITION | BEIERSDORF AG (DE) | 2019-06-20 | — | — | WO | disclosed |
| EP-2593075-A2 | A PERSONAL CARE COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED COMPOUND | The Procter and Gamble Company (US) | 2013-05-22 | — | — | EP | disclosed |
| US-20120014900-A1 | Personal Care Composition Comprising a Near-Terminal Branched Compound | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | disclosed |
| WO-2012009523-A2 | A PERSONAL CARE COMPOSITION COMPRISING A NEAR-TERMINAL BRANCHED COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120014900-A1 | Personal Care Composition Comprising a Near-Terminal Branched Compound | CUTA, KRT18, PARN | DGKA 2280/4885MAPT 763/4885PRSS1 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.